Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04330482 · ClinicalTrials.gov registry record · NA

Translating a Dementia Caregiver Intervention Into a Mobile Application

A NA study, sponsored by Rhode Island Hospital.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT04330482: Completed NA study, sponsored by Rhode Island Hospital.

NCT04330482 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04330482, a NA study, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The overall goal of this development project is to combine elements of two efficacious interventions into a mobile health (mHealth) App for informal dementia caregivers. The investigators will conduct a 3-month feasibility trial of the newly-developed CARE-Well App in 40 dementia caregivers to establish acceptability and feasibility of the intervention, study procedures, and outcome measures.

Primary Outcome

Percentage of participants who decline participation because of randomization.

Interventions

  • BEHAVIORAL CARE-Well App
  • BEHAVIORAL Internet Links

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-01-13
Est. Completion 2022-05-30
Phase NA
Rhode Island Hospital

130 total trials

What the finished NCT04330482 record still lists

NCT04330482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which CARE-Well App is the first listed.

NCT04330482 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04330482 about?

NCT04330482 is a clinical study titled "Translating a Dementia Caregiver Intervention Into a Mobile Application". The overall goal of this development project is to combine elements of two efficacious interventions into a mobile health (mHealth) App for informal dementia caregivers. The investigators will conduct a 3-month feasibility trial of the newly-developed CARE-Well App in 40 dementia caregivers to estab...

What is the current status of trial NCT04330482?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-01-13. Estimated completion is 2022-05-30.

What interventions are being tested in trial NCT04330482?

The interventions under investigation include: CARE-Well App (BEHAVIORAL), Internet Links (BEHAVIORAL).

Who is sponsoring clinical trial NCT04330482?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04330482's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04330482, the US trial registry maintained by the National Library of Medicine. NCT04330482 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.